News
Insight
Currencies
Columns
Events
Search
Recently Searched
Hot Coins
Trending
Daily Must-Read
English
English
简体中文
한국어
日本語
Tiếng Việt
ไทย
Türkçe
Русский
Favorites
Follow
Comments
Creator Platform
Settings
Sign Out
SIGN IN
Welcome Back
Sign in with Twitter
Sign in with Discord
Sign in with Google
Sign in with Apple
Sign in with Email
Click “Sign in” to agree to Cointime’s
Terms of Service
and acknowledge that Cointime’s
Privacy Policy
applies to you.
Join CoinTime
Sign up with Twitter
Sign up with Discord
Sign up with Email
Already have an account?
Sign in
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
{route = 'sent-email'})" />
{route = 'sent-email'})" >
Sign in
page.Sign up
All Sign in options
All Sign up options
Check your inbox
Click the link we sent to
to sign in.
Click the link we sent to
to sign up.
OK
Bitcoin
$98,565.72
-0.24%
Ethereum
$3,348.97
-0.94%
BNB
$647.40
+1.98%
Optimism
$2.20
+6.62%
Arbitrum
$0.81
+2.56%
Solana
$260.99
-0.27%
Polygon
$0.52
+9.96%
Cosmos
$7.71
+16.44%
Avalanche
$44.06
+20.98%
Bitcoin
$98,565.72
-0.24%
Ethereum
$3,348.97
-0.94%
BNB
$647.40
+1.98%
Optimism
$2.20
+6.62%
Arbitrum
$0.81
+2.56%
Solana
$260.99
-0.27%
Polygon
$0.52
+9.96%
Cosmos
$7.71
+16.44%
Avalanche
$44.06
+20.98%
Home
/
Proteon Therapeutics
/
investors
Proteon Therapeutics
company
Investors
Number of Lead Investors
Number of Investors
14
20
Proteon Therapeutics is funded by 20 investors.
Aqua Spark
and
PFR Life Science
are the most recent investors.
Investor Name
Lead Investor
Funding Round
Aqua Spark
Yes
Post-IPO Equity
PFR Life Science
Yes
Post-IPO Equity
Nutreco
Yes
Post-IPO Equity
European regional development fund (ERDF)
Yes
Grant
Deepfield
Yes
Post-IPO Equity
Abingworth
Yes
Series D
Montis Capital
-
Post-IPO Equity
Seventure Partners
-
Post-IPO Equity
Life Sciences Fund
-
Series D
Inbio Ventures
-
Series D
Bessemer Venture Partners
-
Series D
Devon Park BioVentures
-
Series D
Intersouth Partners
-
Series D
MPM Capital
-
Series D
Pharmstandard
-
Series D
Prism Venture Management
-
Series D
Skyline Ventures
-
Series D
TVM Capital
-
Series D
Vectis Healthcare & Life Sciences Fund
-
Series D
MPM Bio IV NVS Strategic Fund
-
Series B
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
Share
{hover = true;if (isWechat) genQrcode($refs.qrcode);}" @mouseleave="hover = false" :style="{'color': platform.color}" >
Wechat scan to share
Page Link
Favorite
Favorite